ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,768,185 | +1.0% | 414,399 | +26.9% | 0.00% | – |
Q2 2023 | $2,740,577 | -39.9% | 326,648 | -28.8% | 0.00% | – |
Q1 2023 | $4,556,311 | -25.5% | 458,843 | -47.8% | 0.00% | -100.0% |
Q4 2022 | $6,117,513 | -34.4% | 878,953 | -49.7% | 0.00% | -50.0% |
Q3 2022 | $9,330,000 | -0.2% | 1,747,328 | -25.4% | 0.00% | 0.0% |
Q2 2022 | $9,346,000 | -17.1% | 2,342,278 | -7.7% | 0.00% | 0.0% |
Q1 2022 | $11,275,000 | +502.0% | 2,536,636 | +441.6% | 0.00% | – |
Q4 2021 | $1,873,000 | +53.3% | 468,317 | +236.4% | 0.00% | – |
Q3 2021 | $1,222,000 | -63.7% | 139,233 | -53.1% | 0.00% | -100.0% |
Q2 2021 | $3,362,000 | -45.1% | 296,777 | -42.4% | 0.00% | -50.0% |
Q1 2021 | $6,123,000 | -34.5% | 515,392 | -62.2% | 0.00% | 0.0% |
Q4 2020 | $9,355,000 | +20.0% | 1,363,687 | +29.6% | 0.00% | 0.0% |
Q3 2020 | $7,796,000 | +1973.4% | 1,052,219 | +1070.3% | 0.00% | – |
Q2 2020 | $376,000 | +295.8% | 89,907 | +135.3% | 0.00% | – |
Q1 2020 | $95,000 | -44.4% | 38,206 | +30.1% | 0.00% | – |
Q4 2019 | $171,000 | +87.9% | 29,363 | +70.6% | 0.00% | – |
Q3 2019 | $91,000 | -69.9% | 17,215 | -65.8% | 0.00% | – |
Q2 2019 | $302,000 | -78.1% | 50,405 | -66.9% | 0.00% | – |
Q1 2019 | $1,377,000 | +1186.9% | 152,508 | +1077.8% | 0.00% | – |
Q4 2018 | $107,000 | +17.6% | 12,948 | +13.5% | 0.00% | – |
Q2 2018 | $91,000 | +8.3% | 11,409 | +1.4% | 0.00% | – |
Q1 2018 | $84,000 | – | 11,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |